National Quality Use of Medicines Indicators
Quality use of medicines (QUM) involves judicious selection of treatment options (including choice between drug, non-drug and no treatment), appropriate choice of medicine when a medicine is required and safe and effective use of medicines.
The National Quality Use of Medicines Indicators are process indicators. They do not directly measure outcomes from medicines use. They do, however, focus on areas where the link between process and outcome is clearly established, so they are clinically meaningful to clinicians and their patients. They have been developed with input from doctors, pharmacists, nurses, consumers and managers around the country.
This manual is hosted by the NSW Therapeutic Advisory Group website. Individual indicators can be accessed by clicking on the links below.
- Antithrombotic therapy
- Antibiotic therapy
- Medication ordering
- Pain management
- Continuity of care
- Hospital-wide medication management policies
- Acute mental health care
Child-Resistant Packaging - KIDCAP
Some medicines can cause serious harm, even death, if they are accidentally ingested by infants or children. Child-resistant packaging is designed to limit or delay access to medicines. A warning code, KIDCAP, has been added to i.Pharmacy systems in NSW. This information sheet provides pharmacy staff with information about the warning code and the provision of child resistant packaging.Download PDF ~345KB
MSQ Connect Newsletters
- MSQ Connect Newsletter May 2020 PDF 209KB
- MSQ Connect Newsletter December 2019 PDF ~287KB
- MSQ Connect Newsletter August 2019 PDF ~236KB
- MSQ Connect Newsletter February 2019 PDF ~308KB
- MSQ Connect Newsletter August 2018 PDF ~182KB
- MSQ Connect Newsletter December 2017 PDF ~349KB
- MSQ Connect Newsletter June 2017 PDF ~490KB
- MSQ Connect Newsletter December 2016 PDF ~406KB
- MSQ Connect Newsletter April 2016 PDF ~311KB